ArticleScientific reports2026
Cymbopogon proximus essential oil promotes wound healing and attenuates inflammation through mechanisms supported by network pharmacology and molecular docking.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cymbopogon proximus Chiov. (Poaceae), widely used in traditional medicine for inflammatory conditions, was investigated for its anti-inflammatory and wound-healing pharmacological potential through an integrated phytochemical, biological, and in silico approach. Essential oils from Cymbopogon proximus and Cymbopogon citratus were isolated by hydrodistillation and chemically characterized by gas chromatography-mass spectrometry coupled with chemometric discrimination. Biological screening first assessed safety and anti-inflammatory activity in vitro using cytotoxicity evaluation, human red blood cell membrane stabilization, and modulation of inflammatory gene expression in lipopolysaccharide-stimulated white blood cells. Based on the superior in vitro profile, C. proximus essential oil was advanced to in vivo pharmacological evaluation in an excisional wound model, with assessment of wound contraction, histopathology, and inflammatory biomarkers. C. proximus exhibited a distinct piperitone-dominant volatile profile and demonstrated stronger anti-inflammatory activity than C. citratus, evidenced by membrane-stabilizing effects and downregulation of key pro-inflammatory mediators, particularly tumor necrosis factor alpha, within non-cytotoxic concentrations. Topical administration accelerated wound closure, improved re-epithelialization, and reduced inflammatory cell infiltration, with activity comparable to a reference topical preparation. Network pharmacology and molecular docking further supported a multi-target mechanism involving inflammation- and repair-related signaling nodes. Collectively, these findings identify C. proximus essential oil as a promising multi-component anti-inflammatory agent with therapeutic potential in inflammation-driven wound repair.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.